WEINSTOCK FOUNDATION

Private Medical Research Foundation
Research Priorities
ocular melanoma

Help Is Our Main Goal

0 +

Labs Seeded

Wienstock Foundation

Purpose and Mission

The Weinstock Foundation is a private foundation dedicated exclusively to advancing scientific research into ocular melanoma, including uveal melanoma, choroidal melanoma, ciliary body melanoma, and iris melanoma. The foundation exists to accelerate discovery, improve survival outcomes, and close critical gaps in understanding a rare but aggressive cancer with limited effective treatments. The foundation’s mission is singular: fund high-quality, translational, and clinically relevant research at major United States universities and academic medical centers capable of producing measurable advances in diagnosis, treatment, and long-term disease control.
Disease Focus

Ocular Melanoma

Ocular melanoma is the most common primary intraocular malignancy in adults, yet it remains an orphan disease in oncology research. Despite successful local tumor control, up to 50% of patients develop metastatic disease, most commonly to the liver, with poor long-term survival. Therapeutic progress has lagged behind that of cutaneous melanoma due to biological differences, limited patient populations, and chronic underfunding.
The foundation recognizes ocular melanoma as a distinct disease entity requiring dedicated research pathways rather than extrapolation from skin melanoma models.

Research Priorities

The Weinstock Foundation prioritizes research programs with strong scientific rigor, institutional capability, and direct relevance to patient outcomes. Priority areas include:
Molecular and Genetic Mechanisms

Molecular and Genetic Mechanisms

  • Tumor initiation and progression pathways
  • Tumor heterogeneity and clonal evolution
  • GNAQ, GNA11, BAP1, SF3B1, EIF1AX mutations
  • Epigenetic drivers and chromosomal aberrations
Metastatic Disease Biology

Metastatic Disease Biology

  • Mechanisms of hepatic tropism
  • Dormancy and late metastasis
  • Microenvironment interactions
  • Immune evasion in uveal melanoma
Therapeutic Development

Therapeutic Development

  • Targeted therapies specific to uveal melanoma biology
  • Immunotherapy strategies adapted to immune-cold tumors
  • Combination therapies and resistance mechanisms
  • Liver-directed and systemic treatment integration
Early Detection and Risk Stratification

Early Detection and Risk Stratification

  • Biomarkers for metastatic risk
  • Liquid biopsy and circulating tumor DNA
  • Prognostic gene expression profiling
  • Imaging and diagnostic innovation
Translational and Clinical Research

Translational and Clinical Research

  • Phase I–III clinical trials
  • Patient-derived models and organoids
  • Real-world data and longitudinal cohorts
  • Precision medicine approaches

Wienstock Foundation

Funding Strategy

The foundation deploys capital strategically to maximize scientific impact rather than dispersing funds broadly. Funding mechanisms include:
  • Investigator-initiated research grants
  • Programmatic multi-year awards
  • Seed funding for novel or high-risk concepts
  • Support for shared research infrastructure
  • Targeted funding for collaborative, multi-institutional efforts

Preference is given to proposals demonstrating:

  • Clear hypotheses and defined endpoints
  • Access to patient samples or clinical cohorts
  • Institutional commitment and co-funding
  • Potential for downstream clinical translation

Institutional Focus

Funding is directed to leading United States universities, academic medical centers, and affiliated research institutes with established oncology, ophthalmology, and translational research programs. The foundation emphasizes institutions with demonstrated capability in:

Cancer genomics and systems biology

Cancer genomics and systems biology

Clinical trial execution

Clinical trial execution

Interdisciplinary collaboration

Interdisciplinary collaboration

Data integrity and regulatory compliance

Data integrity and regulatory compliance

  • Commercial entities are not primary funding recipients unless partnered directly with an academic institution under strict research governance.
You give but little when you give of your possessions. It is when you give of yourself that you truly give.

~ Kahlil Gibran

Weinstock Foundation

Governance and Independence

The Weinstock Foundation operates as a private, non-public charity with independent governance. Funding decisions are based on scientific merit, strategic alignment, and potential impact. The foundation does not engage in political activity, commercial product promotion, or unrelated philanthropic domains.
Scientific advisory input may be obtained from external experts, but final decisions remain with the foundation’s governing body to preserve focus, independence, and mission integrity.

Long-Term Objectives

Accelerate meaningful therapeutic advances for ocular melanoma

Reduce metastatic progression and mortality

Enable earlier intervention through better risk prediction

Support the next generation of researchers in this field

Establish ocular melanoma as a sustained research priority within oncology

Positioning

The Weinstock Foundation exists to address a structural failure in cancer research funding. By concentrating resources on a rare, lethal, and under-served disease, the foundation seeks to produce outsized impact where traditional funding models have been insufficient.
$ 0 M
Moved
0 +
Labs seeded
0
Peer-reviewed papers supported
0
FDA orphan-drug designations influenced
New Project (2)
Scope and Limitations

The foundation does not provide

Individual patient financial assistance

Funding for non-research activities

Support for alternative or non-evidence-based therapies

All funded work must adhere to accepted scientific, ethical, and regulatory standards.

Core Principle

Progress in ocular melanoma will not come from awareness alone. It will come from sustained, disciplined investment in serious science.

Accelerating cures for melanoma and rare ocular cancers through precision philanthropy.
Quick Links
Contact
Copyright © 2026 Wienstock Foundation | Developed by Marquis Global Media